Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
312
archived clinical trials in
Food Studies

Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies
Status: Enrolling
Updated:  12/31/1969
1700
mi
from 43215
Edmonton,
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies
Status: Enrolling
Updated: 12/31/1969
The Metabolomics Innovation Centre
1700
mi
from 43215
Edmonton,
Click here to add this to my saved trials
Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
Status: Enrolling
Updated:  12/31/1969
274
mi
from 43215
Urbana, IL
Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Urbana-Champaign
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
Pasta Formulations and Their Effect on Appetite
Understanding Pasta Formulations on Satiation in Healthy Weight Women
Status: Enrolling
Updated:  12/31/1969
273
mi
from 43215
Chicago, IL
Pasta Formulations and Their Effect on Appetite
Understanding Pasta Formulations on Satiation in Healthy Weight Women
Status: Enrolling
Updated: 12/31/1969
Clinical Nutrition Research Center
273
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Status: Enrolling
Updated:  12/31/1969
1154
mi
from 43215
Aurora, CO
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Status: Enrolling
Updated:  12/31/1969
1687
mi
from 43215
Queretaro,
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet
Status: Enrolling
Updated: 12/31/1969
Universidad Autonoma de Queretaro
1687
mi
from 43215
Queretaro,
Click here to add this to my saved trials
Efficacy and Safety of Stannsoporfin in Neonates
A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants.
Status: Enrolling
Updated:  12/31/1969
416
mi
from 43215
Philadelphia, PA
Efficacy and Safety of Stannsoporfin in Neonates
A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants.
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Hospital
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Assessing Risk of Food Insecurity Within Households of Children With Food Allergy
Assessing Risk of Food Insecurity Within Households of Children With Food Allergy
Status: Enrolling
Updated:  12/31/1969
622
mi
from 43215
Little Rock, AR
Assessing Risk of Food Insecurity Within Households of Children With Food Allergy
Assessing Risk of Food Insecurity Within Households of Children With Food Allergy
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers
Teen Connections for Support From Multidisciplinary Professionals & Peers
Status: Enrolling
Updated:  12/31/1969
627
mi
from 43215
Kansas City, KA
Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers
Teen Connections for Support From Multidisciplinary Professionals & Peers
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
Vitamin D Retrospective Study and Role With Disease
Association of Vitamin D With Diabetes, Osteoporosis and Cardiovascular Risk
Status: Enrolling
Updated:  12/31/1969
343
mi
from 43215
Baltimore, MD
Vitamin D Retrospective Study and Role With Disease
Association of Vitamin D With Diabetes, Osteoporosis and Cardiovascular Risk
Status: Enrolling
Updated: 12/31/1969
Baltimore VAMC
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Durham, NC
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Status: Enrolling
Updated: 12/31/1969
Duke University - with Piedmont Health Services, Inc.
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages
RCT Double Blinded Evaluation of Changes in Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages in Adults Who Are Vitamin D Insufficient
Status: Enrolling
Updated:  12/31/1969
643
mi
from 43215
Boston, MA
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages
RCT Double Blinded Evaluation of Changes in Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages in Adults Who Are Vitamin D Insufficient
Status: Enrolling
Updated: 12/31/1969
Boston University Medical Campus
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Impact of a Nutrition Quality Improvement Program on Outcomes of Malnourished Patients
Assessing the Impact of a Comprehensive Nutrition-Focused Quality Improvement Program (QIP) on Health and Economic Outcomes of Malnourished Adult Patients Across the Continuum of Care
Status: Enrolling
Updated:  12/31/1969
291
mi
from 43215
Des Plaines, IL
Impact of a Nutrition Quality Improvement Program on Outcomes of Malnourished Patients
Assessing the Impact of a Comprehensive Nutrition-Focused Quality Improvement Program (QIP) on Health and Economic Outcomes of Malnourished Adult Patients Across the Continuum of Care
Status: Enrolling
Updated: 12/31/1969
Advocate at Home
291
mi
from 43215
Des Plaines, IL
Click here to add this to my saved trials
Impact of a Nutrition Quality Improvement Program on Outcomes of Malnourished Patients
Assessing the Impact of a Comprehensive Nutrition-Focused Quality Improvement Program (QIP) on Health and Economic Outcomes of Malnourished Adult Patients Across the Continuum of Care
Status: Enrolling
Updated:  12/31/1969
274
mi
from 43215
Oak Lawn, IL
Impact of a Nutrition Quality Improvement Program on Outcomes of Malnourished Patients
Assessing the Impact of a Comprehensive Nutrition-Focused Quality Improvement Program (QIP) on Health and Economic Outcomes of Malnourished Adult Patients Across the Continuum of Care
Status: Enrolling
Updated: 12/31/1969
Advocate at Home- South Office
274
mi
from 43215
Oak Lawn, IL
Click here to add this to my saved trials
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
Hypothesis: Skin Barrier Dysfunction With Altered Expression of Skin Barrier Proteins and Lipids Predicts Early Food Sensitizations in Infants at High Risk of Atopy
Status: Enrolling
Updated:  12/31/1969
1160
mi
from 43215
Denver, CO
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
Hypothesis: Skin Barrier Dysfunction With Altered Expression of Skin Barrier Proteins and Lipids Predicts Early Food Sensitizations in Infants at High Risk of Atopy
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
1160
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 1 - Absorption of Zn and Vitamin A From a Standard Dose
Status: Enrolling
Updated:  12/31/1969
1154
mi
from 43215
Aurora, CO
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 1 - Absorption of Zn and Vitamin A From a Standard Dose
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver, School of Medicine
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 1 - Absorption of Zn and Vitamin A From a Standard Dose
Status: Enrolling
Updated:  12/31/1969
8011
mi
from 43215
Dhaka,
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 1 - Absorption of Zn and Vitamin A From a Standard Dose
Status: Enrolling
Updated: 12/31/1969
icddr,b (International Centre for Diarrheal Disease Research, Bangladesh
8011
mi
from 43215
Dhaka,
Click here to add this to my saved trials
Anxiety About Casual Exposure to Food Allergens
Trial To Reduce Food Allergy Anxiety by Holding the Allergen (TOUCH Study)
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
New York, NY
Anxiety About Casual Exposure to Food Allergens
Trial To Reduce Food Allergy Anxiety by Holding the Allergen (TOUCH Study)
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from 43215
New York, NY
Click here to add this to my saved trials
Improving Infant Nutrition in Southern Ethiopia
Evaluation of Orange Fleshed Sweet Potato Promotion and the Healthy Baby Toolkit in Southern Ethiopia: a Cluster Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
435
mi
from 43215
Atlanta, GA
Improving Infant Nutrition in Southern Ethiopia
Evaluation of Orange Fleshed Sweet Potato Promotion and the Healthy Baby Toolkit in Southern Ethiopia: a Cluster Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
537
mi
from 43215
Fort Benning, GA
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
US Army, Fort Benning
537
mi
from 43215
Fort Benning, GA
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
322
mi
from 43215
Bethesda, MD
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
524
mi
from 43215
Charleston, SC
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated:  12/31/1969
993
mi
from 43215
Miami, FL
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated: 12/31/1969
MeBO Research
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated:  12/31/1969
3856
mi
from 43215
London,
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
Status: Enrolling
Updated: 12/31/1969
MeBO Research LTD
3856
mi
from 43215
London,
Click here to add this to my saved trials
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Baltimore, MD
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
Status: Enrolling
Updated: 12/31/1969
John Hopkins Asthma and Allergy Center
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
1951
mi
from 43215
San Diego, CA
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
1162
mi
from 43215
Denver, CO
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
188
mi
from 43215
Louisville, KY
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
624
mi
from 43215
Minneapolis, MN
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
2058
mi
from 43215
Medford, OR
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2058
mi
from 43215
Medford, OR
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
1953
mi
from 43215
Mission Viejo, CA
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1953
mi
from 43215
Mission Viejo, CA
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
643
mi
from 43215
Boston, MA
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
622
mi
from 43215
Little Rock, AR
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
2005
mi
from 43215
Seattle, WA
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
2100
mi
from 43215
Stanford, CA
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
394
mi
from 43215
Madison, WI
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
2092
mi
from 43215
San Jose, CA
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2092
mi
from 43215
San Jose, CA
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
344
mi
from 43215
Baltimore, MD
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
98
mi
from 43215
Cincinnati, OH
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated:  12/31/1969
524
mi
from 43215
Charleston, NC
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult and Adolescent Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
524
mi
from 43215
Charleston, NC
Click here to add this to my saved trials
Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
Prospective, Open-Label, Randomized, Two-Period, Two-Sequence, Crossover Study Comparing RP-G28 Administered in the Fasted State and the Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
993
mi
from 43215
Miami, FL
Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
Prospective, Open-Label, Randomized, Two-Period, Two-Sequence, Crossover Study Comparing RP-G28 Administered in the Fasted State and the Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Syneos Health
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients An Open-label Prospective Clinical Trial
Status: Enrolling
Updated:  12/31/1969
1928
mi
from 43215
Riverside, CA
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients An Open-label Prospective Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Riverside Medical Center
1928
mi
from 43215
Riverside, CA
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
1048
mi
from 43215
Lampasas, TX
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1048
mi
from 43215
Lampasas, TX
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
2027
mi
from 43215
Lincoln, CA
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2027
mi
from 43215
Lincoln, CA
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
1951
mi
from 43215
San Diego, CA
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
711
mi
from 43215
Gainesville, FL
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
711
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
792
mi
from 43215
Orlando, FL
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
492
mi
from 43215
Great Neck, NY
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
489
mi
from 43215
Hartsdale, NY
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
489
mi
from 43215
Hartsdale, NY
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
283
mi
from 43215
Knoxville, TN
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated:  12/31/1969
991
mi
from 43215
Houston, TX
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials